- Home
- PDS vs MDXG Comparison
PDS vs MDXG Comparison
Compare PDS & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDS | MDXG |
|---|---|---|
| Founded | 1951 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 918.1M | 1.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PDS | MDXG |
|---|---|---|
| Price | $71.73 | $6.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $99.00 | $11.00 |
| AVG Volume (30 Days) | 87.7K | ★ 820.5K |
| Earning Date | 02-11-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.98 | 0.27 |
| Revenue | ★ $1,316,232,437.00 | $393,442,000.00 |
| Revenue This Year | N/A | $19.13 |
| Revenue Next Year | $2.89 | $2.11 |
| P/E Ratio | $24.08 | ★ $23.44 |
| Revenue Growth | N/A | ★ 14.77 |
| 52 Week Low | $36.20 | $5.79 |
| 52 Week High | $75.25 | $9.36 |
Technical Indicators
Market Signals| Indicator | PDS | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 64.05 | 35.10 |
| Support Level | $68.85 | $6.74 |
| Resistance Level | $75.25 | $7.13 |
| Average True Range (ATR) | 1.98 | 0.23 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 61.62 | 11.72 |
Price Performance
Historical ComparisonAbout PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.